Kirkland & Ellis International LLP
Client SatisfactionDescribed as ‘one of the best teams in life sciences and healthcare in London’ Kirkland & Ellis International LLP advises a multitude of major life sciences companies on the global formulation and coordination of life science patent litigation strategy. Daniel Lim co-heads the practice and has a proven track record in pharmaceutical and medical device litigation. Fellow co-head Nicola Dagg is a known name for work including strategic patent and product lifecycle advice. Emma Flett completes the leadership team and is geared to advise on the of IP aspects of M&A transactions. SPC disputes relating to biologic and small molecule products are a practice strength of Steven Baldwin, while Jin Ooi works extensively on follow-on damages inquiry mandates.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is one of the best teams in life sciences and healthcare in London today.'
- 'The team is extremely impressive, with real strength and depth. Members of the team work seamlessly together to achieve the best outcome for the client. The team's technical, legal and commercial knowledge is exceptional. ’
‘Nicola Dagg - a star. Highly intelligent, she understands her client's needs and objectives and is able to utilise her legal talent to obtain fantastic results.'
- 'Jin Ooi - a standout member of the Kirkland team - clever, conscientious and a joy to work with. A talent with a real understanding of patent law in the healthcare field.'
‘The major strength of the life sciences team at Kirkland is the depth of their technical knowledge. It is just second to none. ’
‘I am a barrister who works with Kirkland in intellectual property cases, esp. patent litigation. The Kirkland team has great strength in life sciences cases. Like by the highly dynamic force of nature that is Nicola Dagg, clients love them and come back regularly. You only have to the look at the cases they are in and the clients they represent to see how well regarded they are. The other partners are equally strong and the associates are hardworking and bright. ’
‘Nicola Dagg is the head of the IP team and is amazing at bringing the work in she effectively manages her team to keep all the plates spinning.'
- 'Daniel Lim is excellent on medical device cases. Jin Ooi has as a nose for a good point. ’
Key clients
- Warner-Lambert Company LLC (part of the Pfizer group)
- Viatris
- British American Tobacco (reduced risk products)
- Pfizer
- Alcon
- Advanced Bionics
- Pharmathen
- Siemens Healthineers
- Meril Life Sciences
Work highlights
- Instructed by Astellas and he Regents of the University of California on an end of patent life/lifecycle management mandate in relation to Astellas’ prostate cancer treatment Xtandi.
- Successfully represented Pfizer in relation to its patent revocation action against Amgen to ‘clear the way’ for a BCMA/CD3 bispecific antibody for the treatment of cancer (in particular multiple myeloma) being developed by Pfizer.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Daniel Lim, Nicola Dagg, Emma Flett